Murray S. Webb

3.5k total citations
47 papers, 2.7k citations indexed

About

Murray S. Webb is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Murray S. Webb has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Biomaterials. Recurrent topics in Murray S. Webb's work include Lipid Membrane Structure and Behavior (15 papers), Nanoparticle-Based Drug Delivery (13 papers) and RNA Interference and Gene Delivery (10 papers). Murray S. Webb is often cited by papers focused on Lipid Membrane Structure and Behavior (15 papers), Nanoparticle-Based Drug Delivery (13 papers) and RNA Interference and Gene Delivery (10 papers). Murray S. Webb collaborates with scholars based in Canada, United States and Sweden. Murray S. Webb's co-authors include Marcel B. Bally, Beverley R. Green, Peter L. Steponkus, Ryan Gallagher, Lawrence D. Mayer, Nancy Dos Santos, L.D. Mayer, Christine Allen, Sharon A. Johnstone and Malathi Anantha and has published in prestigious journals such as PLoS ONE, PLANT PHYSIOLOGY and Radiology.

In The Last Decade

Murray S. Webb

47 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray S. Webb Canada 28 1.6k 938 424 312 249 47 2.7k
Dieter Schubert Germany 25 1.6k 1.0× 529 0.6× 460 1.1× 129 0.4× 113 0.5× 82 3.0k
Gerhard Gröbner Sweden 33 2.0k 1.3× 387 0.4× 134 0.3× 228 0.7× 107 0.4× 105 3.4k
Eggehard Holler Germany 36 2.3k 1.5× 1.5k 1.6× 1.2k 2.7× 204 0.7× 513 2.1× 145 4.4k
Toru Kawanishi Japan 31 2.1k 1.3× 250 0.3× 208 0.5× 96 0.3× 204 0.8× 173 3.6k
Milton B. Yatvin United States 25 1.6k 1.0× 880 0.9× 871 2.1× 60 0.2× 127 0.5× 112 3.1k
Andrew S. Janoff United States 29 1.5k 1.0× 863 0.9× 429 1.0× 38 0.1× 268 1.1× 50 2.7k
Alex F. Drake United Kingdom 32 1.7k 1.1× 331 0.4× 282 0.7× 111 0.4× 216 0.9× 115 3.2k
Gary W. Ashley United States 33 2.3k 1.5× 303 0.3× 351 0.8× 192 0.6× 338 1.4× 93 3.9k
Anton I.P.M. de Kroon Netherlands 34 2.9k 1.8× 280 0.3× 256 0.6× 148 0.5× 157 0.6× 92 3.8k
Tudor Arvinte Switzerland 26 1.5k 1.0× 278 0.3× 269 0.6× 75 0.2× 122 0.5× 60 2.1k

Countries citing papers authored by Murray S. Webb

Since Specialization
Citations

This map shows the geographic impact of Murray S. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray S. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray S. Webb more than expected).

Fields of papers citing papers by Murray S. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray S. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray S. Webb. The network helps show where Murray S. Webb may publish in the future.

Co-authorship network of co-authors of Murray S. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Murray S. Webb. A scholar is included among the top collaborators of Murray S. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray S. Webb. Murray S. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lo, Bernard C., Michael R. Hughes, R. Wilder Scott, et al.. (2016). Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice. PLoS ONE. 11(3). e0151765–e0151765. 39 indexed citations
2.
Waterhouse, Dawn, Brent W. Sutherland, Nancy Dos Santos, et al.. (2014). Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. Investigational New Drugs. 32(6). 1071–1082. 12 indexed citations
3.
Donohue, Elizabeth, Anitha Thomas, Norbert Maurer, et al.. (2013). The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model. Journal of Cancer. 4(7). 585–596. 88 indexed citations
4.
Hare, Jennifer I., Malathi Anantha, Nancy Dos Santos, et al.. (2013). Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil. PLoS ONE. 8(4). e62349–e62349. 26 indexed citations
5.
Santos, Nancy Dos, Christine Allen, Malathi Anantha, et al.. (2007). Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(6). 1367–1377. 292 indexed citations
6.
Webb, Murray S., et al.. (2007). Liposomal Drug Delivery: Recent Patents and Emerging Opportunities. Recent Patents on Drug Delivery & Formulation. 1(3). 185–194. 15 indexed citations
7.
Webb, Murray S., Sharon A. Johnstone, Ryan Gallagher, et al.. (2006). In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine. European Journal of Pharmaceutics and Biopharmaceutics. 65(3). 289–299. 29 indexed citations
8.
Tardi, Paul, Ryan Gallagher, Sharon A. Johnstone, et al.. (2006). Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(3). 678–687. 110 indexed citations
9.
Ramsay, Euan, Malathi Anantha, Amandeep Taggar, et al.. (2006). Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation. Pharmaceutical Research. 23(12). 2799–2808. 42 indexed citations
10.
Webb, Murray S., David L. Saltman, Joseph M. Connors, & James H. Goldie. (2002). A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 43(5). 975–982. 8 indexed citations
11.
Webb, Murray S., et al.. (2001). Toxicity and Toxicokinetics of a Phosphorothioate Oligonucleotide Against the c- myc Oncogene in Cynomolgus Monkeys. Antisense and Nucleic Acid Drug Development. 11(3). 155–163. 24 indexed citations
12.
Webb, Murray S., Frances M. P. Wong, Howard J. Lim, et al.. (1998). Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1372(2). 272–282. 146 indexed citations
13.
Webb, Murray S., Peter M. Kanter, Karen A. Gelmon, et al.. (1998). Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer. Cancer Chemotherapy and Pharmacology. 42(6). 461–470. 54 indexed citations
14.
Lee, V S, Murray S. Webb, S. Martinez, Christopher P. McKay, & George S. Leight. (1996). Uremic leontiasis ossea: "bighead" disease in humans? Radiologic, clinical, and pathologic features.. Radiology. 199(1). 233–240. 40 indexed citations
15.
Webb, Murray S., et al.. (1995). The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: Implications for drug delivery. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1238(2). 147–155. 39 indexed citations
16.
Webb, Murray S., Thomas C. Irving, & Peter L. Steponkus. (1995). Effects of plant sterols on the hydration and phase behavior of DOPE/DOPC mixtures. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1239(2). 226–238. 37 indexed citations
17.
Webb, Murray S., Matsuo Uemura, & Peter L. Steponkus. (1994). A Comparison of Freezing Injury in Oat and Rye: Two Cereals at the Extremes of Freezing Tolerance. PLANT PHYSIOLOGY. 104(2). 467–478. 126 indexed citations
18.
Webb, Murray S. & Peter L. Steponkus. (1993). Freeze-Induced Membrane Ultrastructural Alterations in Rye (Secale cereale) Leaves. PLANT PHYSIOLOGY. 101(3). 955–963. 40 indexed citations
19.
Webb, Murray S., Sek Wen Hui, & Peter L. Steponkus. (1993). Dehydration-induced lamellar-to-hexagonal-II phase transitions in DOPE/DOPC mixtures. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1145(1). 93–104. 68 indexed citations
20.
Webb, Murray S., Daniel V. Lynch, & Beverley R. Green. (1992). Effects of Temperature on the Phase Behavior and Permeability of Thylakoid Lipid Vesicles. PLANT PHYSIOLOGY. 99(3). 912–918. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026